Healthcare providers interested in broadening their knowledge of the science and clinical management of inhibitors are invited to participate in NHF’s webinar on “Current Research and Future Approaches to Eradicating Inhibitors in Hemophilia.” This CME and CNE-accredited activity reviews the basic science behind the development of inhibitor antibodies to treatment for hemophilia, the associated management complications and current barriers to research.
Presented by five expert healthcare providers with experience in both bleeding disorders clinical care and research, the webinar also covers the value of inhibitor surveillance, more effective clinical trials and efforts underway by scientists, healthcare providers and government agencies to advance the research road ahead. The webinar is jointly-provided by the National Hemophilia Foundation (NHF) and the Postgraduate Institute for Medicine.
This educational activity was supported by a cooperative agreement funded by the Centers for Disease Control and Prevention (CDC). It will be available for credit until March 31, 2019.
